A gel that could help the cervix heal from HPV?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participant aged 30 to 50 years, inclusive. * Able to read and understand the participant information sheet and informed consent form. * Willing to participate and able to provide written informed consent. * Normal cervical cytology or cervical cytology showing atypical squamous cells of undetermined significance (ASC-US), low-grade squamous intraepithelial lesion (LSIL), or atypical glandular cells (AGC), with corresponding colposcopic findings at baseline. * Cervical cytology obtained no more than 3 months before the baseline/randomization visit. * Positive test for human papillomavirus (HPV) by polymerase chain reaction (PCR) at baseline. * HPV PCR test obtained no more than 3 months before the baseline/randomization visit. * Exocervical mucosal restoration score of 3 or lower on the 5-point colposcopic scale at baseline. * Baseline colposcopy performed no more than 3 months before randomization; the score may be determined from previously recorded images when available in the medical record. * Considered by the investigator able to follow the study instructions, attend the required visits, and complete the study assessments. Exclusion Criteria: * Clinically relevant immune-system disorder, autoimmune disease, or current treatment with immunosuppressive medication. * Systemic or local treatment with antibiotics, antifungal agents, or another treatment that may alter the microbiota within 4 weeks before baseline/randomization. * Undiagnosed abnormal genital bleeding during the 6 months before screening. * Symptomatic vulvovaginal infection. * Surgical cervical excision within the previous year, cervical conization within the previous 6 months, or previous total hysterectomy. * Previous gynecological cancer. * Current participation in another clinical study or participation in another clinical study within 4 weeks before screening. * Planned surgery that could prevent adherence to the study treatment schedule. * Use of vaginal contraceptives or other vaginal hormonal treatments. * Contraindication to the vaginal gel or known allergy to any of its components. * Pregnant, suspected to be pregnant, breastfeeding, or of childbearing potential and not using an effective contraceptive method.